Study Objectives: There is little information about familial aggregation of insomnia; however, this type of information is important to (1) improve our understanding of insomnia risk factors and (2) to design more effective treatment and prevention programs. This study aimed to investigate evidence of familial aggregation of insomnia among first-degree relatives of probands with and without insomnia. Methods: Cases (n = 134) and controls (n = 145) enrolled in a larger epidemiological study were solicited to invite their first-degree relatives and spouses to complete a standardized sleep/insomnia survey. In total, 371 first-degree relatives (M age = 51.9 years, SD = 18.0; 34.3% male) and 138 spouses (M age = 55.5 years, SD = 12.2; 68.1% male) completed the survey assessing the nature, severity, and frequency of sleep disturbances. The dependent variable was insomnia in first-degree relatives and spouses. Familial aggregation was claimed if the risk of insomnia was significantly higher in the exposed (relatives of cases) compared to the unexposed cohort (relatives of controls). The risk of insomnia was also compared between spouses in the exposed (spouses of cases) and unexposed cohort (spouses of controls). Results: The risk of insomnia in exposed and unexposed biological relatives was 18.6% and 10.4%, respectively, yielding a relative risk (RR) of 1.80 (p = .04) after controlling for age and sex. The risk of insomnia in exposed and unexposed spouses was 9.1% and 4.2%, respectively; however, corresponding RR of 2.13 (p = .28) did not differ significantly. Conclusions: Results demonstrate evidence of strong familial aggregation of insomnia. Additional research is warranted to further clarify and disentangle the relative contribution of genetic and environmental factors in insomnia.
Insomnia is a highly prevalent and heterogeneous condition, presumed to result from a multifactorial etiology. Several predisposing factors of insomnia have been recognized, including demographic (e.g., female, sex, aging), psychological (e.g., anxiety), health-related (e.g., illness), and in particular, familial/hereditary variables. [1] [2] [3] Indeed, the risk of insomnia is almost 3 times higher in individuals with a positive family history of insomnia (i.e., at least 1 parent or sibling with insomnia) than individuals without a positive family history. 1 Although detecting family history as a risk factor for insomnia is the first piece of evidence that familial/hereditary is involved in the etiology of insomnia, a better understanding of familial aggregation requires precise assessments of each family member within a family. Several studies have documented familial aggregation in other sleep disorders including restless leg syndrome, obstructive sleep apnea, and narcolepsy [4] [5] [6] ; however, only a handful of studies have investigated familial aggregation specifically in insomnia (discussed in the following).
Familial aggregation is the clustering of individuals affected with a specific disease within families and is often the first step in exploring whether the disease is partially hereditary. 7 Notably, a majority of past studies have used a case-control design to estimate the risk of having a positive family history of insomnia. Based on clinical-and population-based samples, rates of self-reported positive family histories of insomnia range from 39% to 72% in adults with insomnia compared with 24-29% in adults without insomnia. 8, 9 Moreover, rates of a positive family history of insomnia are particularly higher in patients with (1) early-vs. late-age onset insomnia, [8] [9] [10] (2) primary vs. psychiatric insomnia (73% vs. 43%), 8 and (3) in patients with a history of insomnia as compared with patients without a history of insomnia (39% vs. 29%). 9 While the limited data suggest a link between insomnia and self-report family history, methodological shortcomings limit the interpretation of the data and compromise the accuracy of reported rates. For instance, most of the studies included clinical rather than population-based samples, 8, 10, 11 assessed general sleep disturbances rather than insomnia syndrome specifically, 10, 11 or obtained little data on the history of insomnia in the spouses of probands. More importantly, the assessment of family history of insomnia was indirectly obtained from probands. Taken together, such limitations bias and question the integrity of previous results. 12 To the best of our knowledge, no studies have used a reconstructed cohort design approach to examine familial aggregation of insomnia. This design focuses on the disease status (i.e., presence/absence of insomnia) in relatives as a function of exposure or non-exposure to an individual affected with insomnia (i.e., being related to a case or control, respectively). The risk of insomnia in relatives can then be estimated and compared between exposed and unexposed cohorts of relatives. 13 This design is deemed advantageous, as it yields unbiased risk estimates of a disease 14, 15 and allows for the identification and assessment of disease risk factors (e.g., age of onset) in relatives and probands.
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Statement of Significance
This is the first and largest study to quantify familial aggregation of insomnia in relatives of prior (e.g., parents), same (e.g., siblings), and successive generations (e.g., offspring). Evidence indicates there is a strong familial aggregation of insomnia. Future studies should evaluate the impact of early prevention or intervention programs in preventing the development of insomnia among at-risk individuals.
To overcome past limitations, the present study directly gathered detailed evaluations on the presence or absence of insomnia in relatives that were in the exposed (i.e., related to an individual affected with insomnia; case) or in the unexposed cohort (i.e., related to an individual without insomnia; control). The primary aim of this study was to assess the evidence of familial aggregation of insomnia by demonstrating that the risk of insomnia in biological relatives related to cases exceeds that of relatives related to controls. To compare the effects of environmental and genetic effects on insomnia, the risk of insomnia in spouses of cases was also compared with that of spouses of controls. The primary dependent variable was the presence of insomnia in biological relatives and spouses. Familial aggregation was claimed if the risk of insomnia was significantly higher in the exposed cohort compared to the unexposed cohort.
METHOD Study Context and Design
First Level of Recruitment: Cases and Controls
In the first level of recruitment, individuals affected with insomnia and individuals without insomnia were enrolled in a larger longitudinal population-based epidemiological study (Québec, Canada) (see Figure 1) . The aim of this longitudinal study was to document the natural history and treatment of insomnia; its larger context has been previously described. 17 Briefly, the study began with a telephone survey using random digit dialing and the Kish method. 18 At the end of the telephone interview, individuals were invited to take part in the longitudinal phase of the study and those who agreed completed 6 postal assessments on their sleep, health, and psychological status over a 5-year period. Based on their responses at each assessment, individuals were classified into 1 of 3 sleep status groups: insomnia syndrome, insomnia symptoms, or good sleep.
Insomnia Syndrome. Insomnia syndrome was based on a combination of diagnostic criteria from the DSM-IV-TR 19 and the ICD-10 20 as determined by responses to the Insomnia Severity Index (ISI) 21 and the Pittsburgh Sleep Quality Index (PSQI). 22 Criteria included dissatisfaction with sleep, symptoms of initial, middle, or late insomnia 3 nights or more per week for at least a month, and daytime impairments related to sleep problems. Individuals using prescribed medication 3 nights or more per week were also included in this subgroup. Insomnia Symptoms. Criteria included symptoms of initial, middle, or late insomnia 3 nights or more per week without meeting all the diagnostic criteria for an insomnia syndrome. Individuals who were dissatisfied with their sleep but did not present symptoms of initial, middle, or late insomnia were also included in this group. Additional criteria included use of prescribed medication or over-the-counter sleep-promoting products for a minimum of 1 night but less than 3 nights per week.
Good Sleep. Criteria included satisfaction with sleep patterns, no symptoms of initial, middle, or late insomnia, and no use of prescribed or over-the-counter medication to promote sleep.
Cases and Controls.
Cases for the current study were defined as individuals meeting criteria for an insomnia syndrome ≥50% of the 6 assessments and meeting criteria for either insomnia symptoms or syndrome in the last 2 (i.e., most recent) assessments. Controls for the current study were defined as individuals meeting criteria for good sleep on all 6 assessments, except for 2 subjects meeting criteria for symptoms at the last 2 assessments. Selected cases and controls were matched on age (±7 years) and sex and asked to solicit their biological relatives and spouses to participate in the present study (described in the following).
From a potential of 300 selected cases and controls, 134 cases (M age = 50.8 years, SD = 13.5; 28.4% male) and 145 controls (M age = 50.1 years, SD = 14.0; 28.3% male) agreed to solicit at least a relative and/or a spouse. The number of siblings, offspring, and spouses that each case and control had was obtained via self-report from the larger longitudinal study (no information on living parents was obtained). Cases had 807 (475 siblings, 242 offspring, and 90 spouses) and controls had 818 (474 siblings, 243 offspring, and 101 spouses) potential relatives and spouses to solicit to the study. From their potential pool, cases solicited 84 (17.7%) siblings, 59 (24.4%) offspring, and 66 (73.3%) spouses; controls solicited 60 (12.7%) siblings, 72 (29.6%) offspring, and 72 (71.3%) spouses. As for parents, cases recruited 45 and controls recruited 51 for the present study.
Second Level of Recruitment: Biological Relatives/Spouses of a Case or Control
In the second level of recruitment (see Figure 1) , enrolled biological relatives and spouses were reconstructed into 2 cohorts based on their relation with a case or control. Biological relatives and spouses related to a case were reconstructed to form the exposed cohort (i.e., exposure to insomnia) and biological relatives and spouses related to a control were reconstructed to form the unexposed cohort (i.e., non-exposure to insomnia). Biological relatives were first-degree relatives of a case or control (i.e., parent, sibling, or offspring 18 years or older).
Spouses were married or had a common-law relationship with a case or control, were 18 years or older, and living together under the same roof, for at least a year. The inclusion of spouses provided a unique opportunity to compare non-biological relatives living in similar environments of probands with that of biological relatives who share similar genetic components and possibly also share(d) similar environmental factors (e.g., siblings during development). As such, spouses served to delineate the environmental from the genetic effects on insomnia in comparison to biological relatives. All biological relatives and spouses provided consent and information on their demographics and a detailed assessment of their sleep patterns and difficulties.
Procedure
Between February and September 2013, research assistants contacted cases by email or by phone to explain the nature and objectives of the study. Cases were invited to recruit a minimum of 1 (there was no limit) biological relative(s) and/or spouse to complete a sleep survey. Cases who agreed provided contact information of their biological relative(s) and spouse, and research assistants contacted them to solicit their participation. When a case recruited a relative and/or spouse, an age-and sex-matched control was selected and was invited to recruit a biological relative and/or spouse using the same procedure described above.
Based on preference, participants (i.e., biological relatives, spouses) could complete a paper or an online version of the sleep questionnaire. The paper version was sent by mail. The online questionnaire was made available on the FluidSurvey® platform, a Canadian-based online survey website company (http://fluidsurveys.com). Email invitations with a unique link to the online survey were distributed to participants. Participants were given 2 weeks to complete the survey. Reminders were sent 1 week after the survey was made available. Participants were compensated CAD$10 upon completion of the questionnaire.
Measures
The questionnaire in the present study was comprised of 2 parts: socio-demographic and sleep/insomnia information. The sleep and insomnia section was similar to that completed by cases and controls in the larger study and included the ISI 21 and the PSQI. 
Socio-demographic Information
Participants reported their sex, age, the nature of their relationship (parent, sibling, offspring, or spouse) with the case or control, whether they were biologically related to the case or control (yes or no), and whether they presently lived under the same roof with the case or controls (yes or no).
Insomnia Severity Index
The ISI 21 is a 7-item self-rated scale that yields a quantitative index of insomnia severity. Each item was rated on a 5-point Likert scale and summed to yield a composite score (range: 0-28), with higher scores indicative of severe insomnia. The ISI demonstrates good psychometric properties, and is sensitive to treatment response. 21, 23 Pittsburgh Sleep Quality Index The PSQI 22 is a 19-item, self-rated questionnaire that assesses the sleep quality, sleep disturbances, and sleep patterns. A global score is calculated (range: 0-21), with higher scores indicative of considerable sleep disturbances. Psychometric properties of the PSQI are well recognized. 24 
Statistical Analyses
The method of Liang 25 was used to calculate the relative risks (RR) in all familial aggregation models. This method focuses on the disease status of biological relatives of cases and controls as the outcome measure rather than on insomnia status of cases and controls. First, the RR of insomnia in exposed relatives were compared to unexposed relatives and then were estimated using generalized estimating equations (GEE) to take into account within-family shared variance. Given that these 2 samples of relatives represent cohorts of subjects exposed and unexposed to the risk factor (i.e., being a relative to a case with insomnia), the estimation of familial aggregation of insomnia can be obtained through the calculation of the RR comparing the risk of insomnia in exposed vs. unexposed relatives. The evidence of a genetic component for insomnia will arise if familial aggregation occurs (i.e., RR > 1) among biological relatives (e.g., parents) but not among spouses. The effects of gender were also analyzed; however, the risk of insomnia did not significantly differ between exposed and unexposed cohorts of biological relatives based on gender (data not shown for parsimony). Covariates included relatives' sex and age and statistical significance was set at 0.05 (2-tailed).
RESULTS
A majority of biological relatives were married (63.6%), White (96.7%), working (54.2%), and held a university degree (41.6%) (see Table 1 ). There were 371 biological relatives with a comparable proportion in the exposed cohort (n = 188) and in the unexposed cohort (n = 183) (74.0% vs. 73.7%, p = .57) ( Table 2) . A significantly greater proportion of first-degree male relatives (e.g., brothers, sons) were found in the exposed cohort than in the unexposed cohort (p = .04). No significant differences were observed between exposed and unexposed cohorts of first-degree relatives in the mean age (p = .14) or in the distribution of the type of family members (i.e., parents, siblings, offspring) (p = .06). Siblings in the exposed cohort were significantly older than siblings in the unexposed cohort (59.9 vs. 54.9 years, p = .03); however, no significant age differences were found between exposed and unexposed cohorts of parents (p = .09) or offspring (p = .78).
The risk of insomnia in exposed and unexposed biological relatives was 18.6% and 10.4%, respectively, yielding a relative risk (RR) of 1.80 (p = .04) ( Table 3 ). In particular, the risk of insomnia was almost 5 times more in siblings in the exposed cohort than siblings in the unexposed cohort (23.8% vs. 5.0%), with a corresponding RR of 4.96 (p = .008). The risk of insomnia did not significantly differ between the exposed and unexposed cohorts of offspring (13.6% vs. 9.7%; RR = 1.65, p = .38) or of parents (15.6% vs. 17.6%; RR = 0.84, p = .71).
Overall, spouses were legally married (97.8%), White (95.7%), were working (65.2%), and held a university degree (39.9%) ( Table 1 ). There were 138 spouses with a comparable proportion in the exposed cohort (n = 66) and in the unexposed cohort (n = 72) (p = .57) ( Table 2 ). The proportion of male spouses (p = .47) and the mean age of spouses (p = .78) did not significantly differ between exposed and unexposed cohorts. A higher risk of insomnia was observed in spouses in the exposed cohort than spouses in the unexposed cohort (9.1% vs. 4.2%); however, the RR was non-significant (p = .28) ( Table 3 ).
DISCUSSION
The aim of the present study was to assess the familial risk of insomnia with the direct assessment of biological relatives and spouses related to individuals with and without insomnia. Consistent with the hypothesis, the risk of insomnia was significantly greater in the exposed cohort than in the unexposed cohort of biological relatives. The relative risk of insomnia among exposed and unexposed spouses was non-significant, suggesting that insomnia may have a substantial genetic basis.
This familial risk of insomnia was especially pronounced among siblings. Indeed, the relative risk was almost 5 times higher in siblings with a brother/sister also affected with insomnia than in siblings whose brother/sister did not have insomnia. Such findings corroborate past case-control [8] [9] [10] as well as biological sibling and twin studies that report familial aggregation in coffee-induced insomnia, initial insomnia, 26 and vulnerability to stress-related sleep disturbances (i.e., sleep reactivity). 27 Contrary to expectations, parents and offspring of cases with insomnia showed no greater risk of insomnia compared with parents and offspring of individuals without insomnia. Additionally, no gender effects were observed in the present study. These results are surprising and inconsistent with past studies reporting higher rates of insomnia among parents and in female relatives. [8] [9] [10] The present findings may be attributable to the older parents recruited by their middle-aged probands as well as to the various clinical and socio-cultural factors not examined in the present study (e.g., presence of comorbid psychiatric disorders). Indeed, while prevalence and incidence of insomnia increase with age, "normal" age-related changes in sleep may make it difficult to disentangle clinical vs. normal sleep disturbances in aging, and hence, the influence of genetics in late-life insomnia. The inconsistent findings among offspring 28,29 may also be due to age. Compared to siblings (who were older by 20 years), offspring were younger (M = 34 years), and had less time for insomnia to emerge as a clinical syndrome.
While there is a growing interest in identifying the genetic basis of insomnia, the mechanisms are not well substantiated compared with that of other sleep disorders, such as narcolepsy 30, 31 or restless leg syndrome. 32, 33 Using genetic strategies such as candidate Exposed = a relative of a case affected with insomnia; Unexposed = a relative of a control not suffering from insomnia. gene and genome-wide association studies, heritability coefficients range from 42% to 57% for sleep and insomnia symptoms. 3, 34, 35 Specifically, the neurobiology of insomnia has been linked with genes involved in the neural function (ROR1), 36 circadian rhythm (3111T/C CLOCK), 37 regulation of calcium signaling (CACNA1C, PLCB1), 36, 38 serotonin (5-HTTLPR), 39 and GABAergic inhibition (GABRB3). 40 Recently, a sleep-regulating gene (neuromedin U [Nmu]) was associated with a severe form of insomnia, characterized by substantial reductions in sleep time, increased sleep latency, and increased wake time in zebrafish. 41 Given the high rate of familial aggregation of insomnia, the present findings corroborate the relevance of conducting future studies related to the genetic component of insomnia.
LIMITATIONS, STRENGTHS, AND FUTURE DIRECTIONS
A main limitation of the present study was the use of self-reported data to confirm the presence of insomnia. The absence of a clinical evaluation to validate insomnia diagnosis, other sleep disorders, as well as other psychological or medical co-morbidity in relatives and spouses may have led to the misestimation of aggregation rates. Nevertheless, the classification of insomnia was based on well-established and validated algorithms derived from psychometrically validated questionnaires.
Another limitation was the overall low rate of participation of first-degree relatives despite instructions given to probands to invite all their relatives with and without sleep problems. In familial aggregation studies, it is important to obtain information from all family members. In the present study, probands may have had a tendency to recruit more relatives with a sleep problem than without a sleep problem and/or may have been reluctant to solicit all their first-degree relatives, particularly their parents (i.e., less willing/capable of completing the survey). Additionally, the small number of spouses with insomnia may have accounted for the non-significant findings within this group. However, it should be noted that this is the first study to obtain direct information from spouses of both cases and controls. Only 1 other study has included spouses of cases and they reported a rate of insomnia that was similar to rate in the present study. 8 Future studies should include the participation of all first-degree relatives and spouses, assess medical and psychiatric comorbidities, medication use, and evaluate for sleep disorders other than insomnia. Factors related to genetic susceptibility of insomnia should also be investigated in future familial aggregation studies (e.g., gender, assortative mating, shared [sleep] environment, stressors). In addition, future studies should examine families with strong insomnia aggregation (i.e., cluster of relatives related to a case) and attempt to document unique phenotypic characteristics within these families, such as physiological (e.g., hyperarousal), psychological (e.g., anxiety), behavioral (e.g., medication use), and other clinical variables (e.g., age of onset, insomnia severity) associated with family aggregation. Research on phenotypes are required to fully validate and to test candidate genes, to perform gene-wide association studies and to perform linkage analysis or whole exome sequencing in the high segregated insomnia families. Collectively, this information has potential implications in providing guidance about preexisting vulnerability phenotypes and whether/when screening should be offered to family members of patients with insomnia. 42, 43 To the best of our knowledge, this is the first and largest study to quantify familial aggregation of insomnia in relatives of prior (e.g., parents), same (e.g., siblings), and successive generations (e.g., offspring) as well as spouses of both cases and controls. 8 Moreover, this study was the first to use a reconstructed cohort design and obtain data directly from relatives and spouses 8 , thereby reducing misclassification and enhancing power. 7, 14, 15 In summary, this study provides evidence of strong familial aggregation of insomnia. The main implication of these findings is that future studies should evaluate the impact of early prevention or intervention programs in preventing the development of insomnia among at-risk individuals.
